Description:

NSABP PROTOCOL C-09: Treatment Form for Group 1 Patients NCT00268463 Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FCBE2AD1-8223-57D3-E034-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FCBE2AD1-8223-57D3-E034-0003BA3F9857

Keywords:
Versions (3) ▾
  1. 8/27/12
  2. 1/8/15
  3. 6/3/15
Uploaded on:

June 3, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

NSABP PROTOCOL C-09: Treatment Form for Group 1 Patients NCT00268463

Submit this form when protocol treatment has ended in a Group 1 patient, or when it is certain patient will not receive protocol therapy

Header module
Are data amended (Check box if yes, and circle amended items)
cm
Assessment of Chemotherapy
Kg
Was less than full dose administered because of toxicity?
Why did treatment end or not begin (CAPECITABINE Select primary reason)
Why did treatment end or not begin (CAPECITABINE Select primary reason)

Similar models